Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242
Clinical trial NCT03785054 · COMPLETED
Trial details
- NCT number
- NCT03785054
- Sponsor
- Nxera Pharma UK Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2021-03-11
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.